Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...

Foods IBS Provides Personalized Diet Therapy for Patients Suffering with Irritable Bowel Syndrome (IBS)Research Finds Patients Following a Personalized Diet Therapy Created with inFoods® IBS, ...

Study participants who went on an IgG-based elimination diet--based on a novel blood test--experienced less abdominal pain than those on a sham diet.

Thetis Pharmaceuticals LLC ("Thetis"), a clinical-stage company developing TP-317, a first-in-class, small molecule drug candidate targeting the BLT1 receptor to treat inflammatory bowel disease (IBD) ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

Foods IBS Provides Personalized Diet Therapy for Patients Suffering with Irritable Bowel Syndrome (IBS)Research Finds Patients Following a Personalized Diet Therapy Created with inFoods® IBS, Experien ...

The combination resulted in a median overall survival (OS) of 9 months for the combination therapy compared to 5.4 months for chemotherapy plus Erbitux, the current standard-of-care treatment ...

Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...

Oral vancomycin therapy resulted in clinical response in nearly half of patients with inflammatory bowel disease associated ...

Connecticut lawmakers are weighing a bill on authorizing electric shock therapy either with or without a person’s consent.

umcutrecht.nl Objective The introduction of anti tumour necrosis factor-α (anti-TNFα) therapy might impact healthcare expenditures, but there are limited data regarding the costs of inflammatory bowel ...